No Detail Found!

Gene Expression of Glyoxalase Ii in Diabetic Retinopathy.

Author(s)
Amber Zaidi Department of Biochemistry, Army Medical College, Rawalpindi, Pakistan
Palvasha Waheed Department of Biochemistry, Army Medical College, Rawalpindi, Pakistan
Amir Rashid Department of Biochemistry, Army Medical College, Rawalpindi, Pakistan
Saleem Ahmed Khan Department of Pathology, Army Medical College, Rawalpindi, Pakistan
Abstract
Objective: To study the gene expression of Glyoxalase II among patients of diabetic retinopathy. Study Design: A cross-sectional comparative study. Place and Duration of Study: CREAM (Centre for Research in Experimental and Applied Medicine) and the Department of Biochemistry and Molecular Biology, Army Medical College, Rawalpindi in collaboration with Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi, from November 2015 to November 2016. Methodology: Individuals were enrolled, among whom 30 were cases with diabetic retinopathy and 30 were controls without the disease. Their relevant data were collected and blood samples were drawn. Individual RNA was extracted from respective samples and cDNA was synthesised from each. Expression analysis for Glyoxalase II was done and relative quantification was done using delta delta CT method. Results: A total of 60 individuals of ages 40-70 years were enrolled in the study, 30 cases and 30 controls. Among these, 34 (56.67%) were males and 26 (43.3%) were females. Mean ages were 60 ±8 years in cases and 59 ±13 years in controls. Down regulation of Glyoxalase II was observed in cases as compared to controls. Conclusion: Downregulation of Glyoxalase II, seen among patients of diabetic retinopathy, may indicate a failure of detoxifying system leading to accumulation of glycated end products.
Publication Details
Page(s) 523-526
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 7, Year: 2018

Request the full text from PASTIC

References
Gordon R MaDJG., 1955.Determination of glyoxalase activity,J Biol Chem 219 605 -10
AllamanI,BelangerM,MagistrettiPJ, 2015.Methylglyoxal, the dark side of glycolysis,Front Neurosci 9 23 -
Sousa SilvaM,GomesRA,FerreiraAE,Ponces FreireA,CordeiroC., 2013.The glyoxalase pathway: the first hundred years,Biochem J 453 1 -15
TomicM,LjubicS,KastelanS,Gverovic AntunicaA,JazbecA,PoljicaninT, 2013.haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes,Mediat Inflam 818671 -
WaseemUllah Memon,ZJ , Umair,Qidwai,TanveerHasan, 2012.Prevalence of diabetic retinopathy in patients of age group 30 years and above attending multicentre diabetic clinics in Karachi,Pak J Opthalmol 28 2 -
RabbaniN,XueM,ThornalleyPJ, 2014.function in the glyoxalase system,Biochem Soc Trans 42 419 -24
BangelFN,YamadaK,AraiM,IwayamaY,BalanS,ToyotaT, 2015.Genetic analysis of the glyoxalase system in schizophrenia,Prog Neuropsychopharmacol Biol Psychiatry 59 105 -10
XueM,RabbaniN,ThornalleyPJ, 2014.Measurement of glyoxalase gene expression,Biochem Soc Trans 42 495 -9
SabrinaR,EmmanuelleL,SylvianneS,CarineN,BertrandF, 2014.Skin protection against dicarbonyl stress by the glyoxalase system,Free Radic Biol Med 75 S19 -20
GuravAN, 2013.Advanced glycation end products: a link between periodontitis and diabetes mellitus?,Curr Diabetes Rev 9 355 -61
MaessenDE,StehouwerCD,SchalkwijkCG, 2015.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases,Clin Sci 128 839 -61
UribarriJ,del CastilloMD,de la MazaMP,FilipR,GugliucciA,Luevano-ContrerasC, 2015.Dietary advanced glycation end products and their role in health and disease,Adv Nutr 6 461 -73
XueJ,RayR,SingerD,BohmeD,BurzDS,RaiV, 2014.The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs,Biochemistry 53 3327 -35
JinX,YaoT,ZhouZ,ZhuJ,ZhangS,HuW, 2015.Advanced glycation end products enhance macrophages polarization into M1 phenotype through activating RAGE/NF-kappaB pathway,BioMed Res Int 732450 -
WautierMP,TessierFJ,WautierJL, 2014.Advanced glycation end products: A risk factor for human health,Ann Pharm Fr 72 400 -8
LivakKJ,SchmittgenTD,Delta Delta C(T)), 2001.Method,Methods 25 402 -8
RabbaniN,XueM,ThornalleyPJ, 2016.Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments,Clin Sci 130 1677 -96
YangL,WuQ,LiY,FanX,HaoY,SunH, 2013.Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population,J Diabetes Res 264579 -
MasterjohnC,ParkY,LeeJ,NohSK,KooSI,BrunoRS, 2013.Dietary fructose feeding increases adipose methylglyoxal accumulation in rats in association with low expression and activity of glyoxalase-2,Nutrients 5 3311 -28
VulesevicB,MilneRW,SuuronenEJ, 2014.Reducing methylglyoxal as a therapeutic target for diabetic heart disease,Biochem Soc Trans 42 523 -7
SkapareE,KonradeI,LiepinshE,StreleI,MakreckaM,BierhausA, 2013.Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients,J Diabetes Complications 27 262 -7
0

Citations

0

Downloads

55

Views